In Vivo Bioluminescence Imaging Validation of a Human Biopsy–Derived Orthotopic Mouse Model of Glioblastoma Multiforme

Glioblastoma multiforme (GBM), the most aggressive brain malignancy, is characterized by extensive cellular proliferation, angiogenesis, and single-cell infiltration into the brain. We have previously shown that a xenograft model based on serial xenotransplantation of human biopsy spheroids in immun...

Full description

Saved in:
Bibliographic Details
Main Authors: Monika A. Jarzabek, Peter C. Huszthy, Kai O. Skaftnesmo, Emmet McCormack, Patrick Dicker, Jochen H.M. Prehn, Rolf Bjerkvig, Annette T. Byrne
Format: Article
Language:English
Published: SAGE Publishing 2013-05-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2012.00029
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841564103042138112
author Monika A. Jarzabek
Peter C. Huszthy
Kai O. Skaftnesmo
Emmet McCormack
Patrick Dicker
Jochen H.M. Prehn
Rolf Bjerkvig
Annette T. Byrne
author_facet Monika A. Jarzabek
Peter C. Huszthy
Kai O. Skaftnesmo
Emmet McCormack
Patrick Dicker
Jochen H.M. Prehn
Rolf Bjerkvig
Annette T. Byrne
author_sort Monika A. Jarzabek
collection DOAJ
description Glioblastoma multiforme (GBM), the most aggressive brain malignancy, is characterized by extensive cellular proliferation, angiogenesis, and single-cell infiltration into the brain. We have previously shown that a xenograft model based on serial xenotransplantation of human biopsy spheroids in immunodeficient rodents maintains the genotype and phenotype of the original patient tumor. The present work further extends this model for optical assessment of tumor engraftment and growth using bioluminescence imaging (BLI). A method for successful lentiviral transduction of the firefly luciferase gene into multicellular spheroids was developed and implemented to generate optically active patient tumor cells. Luciferase-expressing spheroids were injected into the brains of immunodeficient mice. BLI photon counts and tumor volumes from magnetic resonance imaging (MRI) were correlated. Luciferase-expressing tumors recapitulated the histopathologic hallmarks of human GBMs and showed proliferation rates and microvessel density counts similar to those of wild-type xenografts. Moreover, we detected widespread invasion of luciferase-positive tumor cells in the mouse brains. Herein we describe a novel optically active model of GBM that closely mimics human pathology with respect to invasion, angiogenesis, and proliferation indices. The model may thus be routinely used for the assessment of novel anti-GBM therapeutic approaches implementing well-established and cost-effective optical imaging strategies.
format Article
id doaj-art-6ea54ea9094542e399a6333fb05ff756
institution Kabale University
issn 1536-0121
language English
publishDate 2013-05-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-6ea54ea9094542e399a6333fb05ff7562025-01-02T23:12:07ZengSAGE PublishingMolecular Imaging1536-01212013-05-011210.2310/7290.2012.0002910.2310_7290.2012.00029In Vivo Bioluminescence Imaging Validation of a Human Biopsy–Derived Orthotopic Mouse Model of Glioblastoma MultiformeMonika A. JarzabekPeter C. HuszthyKai O. SkaftnesmoEmmet McCormackPatrick DickerJochen H.M. PrehnRolf BjerkvigAnnette T. ByrneGlioblastoma multiforme (GBM), the most aggressive brain malignancy, is characterized by extensive cellular proliferation, angiogenesis, and single-cell infiltration into the brain. We have previously shown that a xenograft model based on serial xenotransplantation of human biopsy spheroids in immunodeficient rodents maintains the genotype and phenotype of the original patient tumor. The present work further extends this model for optical assessment of tumor engraftment and growth using bioluminescence imaging (BLI). A method for successful lentiviral transduction of the firefly luciferase gene into multicellular spheroids was developed and implemented to generate optically active patient tumor cells. Luciferase-expressing spheroids were injected into the brains of immunodeficient mice. BLI photon counts and tumor volumes from magnetic resonance imaging (MRI) were correlated. Luciferase-expressing tumors recapitulated the histopathologic hallmarks of human GBMs and showed proliferation rates and microvessel density counts similar to those of wild-type xenografts. Moreover, we detected widespread invasion of luciferase-positive tumor cells in the mouse brains. Herein we describe a novel optically active model of GBM that closely mimics human pathology with respect to invasion, angiogenesis, and proliferation indices. The model may thus be routinely used for the assessment of novel anti-GBM therapeutic approaches implementing well-established and cost-effective optical imaging strategies.https://doi.org/10.2310/7290.2012.00029
spellingShingle Monika A. Jarzabek
Peter C. Huszthy
Kai O. Skaftnesmo
Emmet McCormack
Patrick Dicker
Jochen H.M. Prehn
Rolf Bjerkvig
Annette T. Byrne
In Vivo Bioluminescence Imaging Validation of a Human Biopsy–Derived Orthotopic Mouse Model of Glioblastoma Multiforme
Molecular Imaging
title In Vivo Bioluminescence Imaging Validation of a Human Biopsy–Derived Orthotopic Mouse Model of Glioblastoma Multiforme
title_full In Vivo Bioluminescence Imaging Validation of a Human Biopsy–Derived Orthotopic Mouse Model of Glioblastoma Multiforme
title_fullStr In Vivo Bioluminescence Imaging Validation of a Human Biopsy–Derived Orthotopic Mouse Model of Glioblastoma Multiforme
title_full_unstemmed In Vivo Bioluminescence Imaging Validation of a Human Biopsy–Derived Orthotopic Mouse Model of Glioblastoma Multiforme
title_short In Vivo Bioluminescence Imaging Validation of a Human Biopsy–Derived Orthotopic Mouse Model of Glioblastoma Multiforme
title_sort in vivo bioluminescence imaging validation of a human biopsy derived orthotopic mouse model of glioblastoma multiforme
url https://doi.org/10.2310/7290.2012.00029
work_keys_str_mv AT monikaajarzabek invivobioluminescenceimagingvalidationofahumanbiopsyderivedorthotopicmousemodelofglioblastomamultiforme
AT peterchuszthy invivobioluminescenceimagingvalidationofahumanbiopsyderivedorthotopicmousemodelofglioblastomamultiforme
AT kaioskaftnesmo invivobioluminescenceimagingvalidationofahumanbiopsyderivedorthotopicmousemodelofglioblastomamultiforme
AT emmetmccormack invivobioluminescenceimagingvalidationofahumanbiopsyderivedorthotopicmousemodelofglioblastomamultiforme
AT patrickdicker invivobioluminescenceimagingvalidationofahumanbiopsyderivedorthotopicmousemodelofglioblastomamultiforme
AT jochenhmprehn invivobioluminescenceimagingvalidationofahumanbiopsyderivedorthotopicmousemodelofglioblastomamultiforme
AT rolfbjerkvig invivobioluminescenceimagingvalidationofahumanbiopsyderivedorthotopicmousemodelofglioblastomamultiforme
AT annettetbyrne invivobioluminescenceimagingvalidationofahumanbiopsyderivedorthotopicmousemodelofglioblastomamultiforme